Therefore, COVID-19 patients with CHD were four times more likely to die than average COVID-19 patients, with an elevated level of proinflammatory cytokines such as IL-6, CRP, and procoagulant factors such as D-Dimer20. Here, IL6 is linked to COVID-19.